Panacea Biotec has received a letter of award (LoA) worth around $35.65 million (around Rs 315 crore) from UNICEF. The LoA is for a long-term agreement for supply of bivalent oral polio vaccine (bOPV) to UNICEF, starting from April 01, 2026 to March 31, 2030.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.